US Calls OxyContin FCA Suit 'Parasitic'

Law360, New York (January 18, 2013, 1:12 PM EST) -- The federal government asked the Fourth Circuit on Wednesday to dismiss a qui tam lawsuit accusing Purdue Pharma LP of falsely marketing painkiller OxyContin, arguing it was a "parasitic follow-on lawsuit" that threatened the integrity of the False Claims Act.

Although a West Virginia federal court had dismissed the suit under the res judicata doctrine — because one of the relators had filed a nearly identical lawsuit that the Fourth Circuit dismissed in 2005 — the U.S. government said the appeals court should affirm the dismissal...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.